Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children

Vaccine

Volumn 24, Issue 44-46, 2006, Pages 6708-6711

  Haaheim, L R ^a   Tomasov, C C ^a   Barr, I G ^a   Hampson, A W ^a   Komadina, N ^a  

^a WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Escape mutants; Genetics; Human sera

Indexed keywords

ADULT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A SOUTH AUSTRALIA 147 99; MALE; NONHUMAN; NORWAY; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEASONAL VARIATION; SEQUENCE ANALYSIS; SERUM; VIROGENESIS; VIRUS CULTURE; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; CELL LINE; CHILD; CHILD, PRESCHOOL; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE SERA; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; VARIATION (GENETICS);

EID: 33846197987     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.088     Document Type: Article

References (11)

1. Wiley D.C., and Skehel J.J. The structure and function of the haemagglutinin membrane glycoprotein of influenza virus. Ann Rev Biochem 56 (1987) 365-394
2. Wilson I.A., and Cox N.J. Structural basis of immune recognition of influenza virus haemagglutinin. Ann Rev Immunol 8 (1990) 737-771
3. Cox N.J., and Bender C.A. The molecular and epidemiology of influenza viruses. Semin. Virol 6 (1997) 359-370
4. Haaheim L.R., and Schild G.C. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 2. Antiviral activities of the antibodies in biological systems. Acta Path Microbiol Scand Sect B 88 (1980) 335-340
5. Haaheim L.R., and Schild G.C. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 3. Selection of antigenic variants in vitro and in vivo. Acta Path Microbiol Scand Sect B 88 (1980) 341-345
6. Wang M.L., Skehel J.J., and Wiley D.C. Comparative analyses of the specificities of anti-influenza haemagglutinin antibodies in human sera. J Virol 57 (1986) 24-28
7. Natali A., Oxford J.S., and Schild G.C. Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody. J Hyg 87 (1981) 185-190
8. Haaheim L.R. Haemagglutination-inhibition antibodies in human sera to an antigenic mutant of influenza A/Texas/1/77 (H3N2) virus obtained in vitro. Acta path Microbiol Scand Sect B 88 (1980) 351-353
9. Oxford J.S., Haaheim L.R., Slepushkin A., Werner J., Kuwert E., and Schild G.C. Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. J Hyg 86 (1981) 17-26
10. Sayle R., and Milner-White E.J. RasMol: biomolecular graphics for all. Trends Biochem Sci (TIBS) 20 9 (1995) 374
11. Macken C., Lu H., Goodman J., and Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus A.D.M.E., Cox N., and Hampson A.W. (Eds). Options for the control of influenza IV (2001), Elsevier Science, Amsterdam 103-106